635 related articles for article (PubMed ID: 25652202)
1. Dual-targeting of aberrant glucose metabolism in glioblastoma.
Shen H; Decollogne S; Dilda PJ; Hau E; Chung SA; Luk PP; Hogg PJ; McDonald KL
J Exp Clin Cancer Res; 2015 Feb; 34(1):14. PubMed ID: 25652202
[TBL] [Abstract][Full Text] [Related]
2. Targeting of two aspects of metabolism in breast cancer treatment.
Gang BP; Dilda PJ; Hogg PJ; Blackburn AC
Cancer Biol Ther; 2014; 15(11):1533-41. PubMed ID: 25482950
[TBL] [Abstract][Full Text] [Related]
3. Alterations in the mitochondrial responses to PENAO as a mechanism of resistance in ovarian cancer cells.
Decollogne S; Joshi S; Chung SA; Luk PP; Yeo RX; Nixdorf S; Fedier A; Heinzelmann-Schwarz V; Hogg PJ; Dilda PJ
Gynecol Oncol; 2015 Aug; 138(2):363-71. PubMed ID: 26080289
[TBL] [Abstract][Full Text] [Related]
4. Activation of mitochondrial oxidation by PDK2 inhibition reverses cisplatin resistance in head and neck cancer.
Roh JL; Park JY; Kim EH; Jang HJ; Kwon M
Cancer Lett; 2016 Feb; 371(1):20-9. PubMed ID: 26607904
[TBL] [Abstract][Full Text] [Related]
5. Sensitization of Glioblastoma Cells to Irradiation by Modulating the Glucose Metabolism.
Shen H; Hau E; Joshi S; Dilda PJ; McDonald KL
Mol Cancer Ther; 2015 Aug; 14(8):1794-804. PubMed ID: 26063767
[TBL] [Abstract][Full Text] [Related]
6. Antitumor and chemosensitizing action of dichloroacetate implicates modulation of tumor microenvironment: a role of reorganized glucose metabolism, cell survival regulation and macrophage differentiation.
Kumar A; Kant S; Singh SM
Toxicol Appl Pharmacol; 2013 Nov; 273(1):196-208. PubMed ID: 24051182
[TBL] [Abstract][Full Text] [Related]
7. Metabolic modulation of glioblastoma with dichloroacetate.
Michelakis ED; Sutendra G; Dromparis P; Webster L; Haromy A; Niven E; Maguire C; Gammer TL; Mackey JR; Fulton D; Abdulkarim B; McMurtry MS; Petruk KC
Sci Transl Med; 2010 May; 2(31):31ra34. PubMed ID: 20463368
[TBL] [Abstract][Full Text] [Related]
8. Targeting of EGFR increase anti-cancer effects of arsenic trioxide: Promising treatment for glioblastoma multiform.
Mesbahi Y; Zekri A; Ahmadian S; Alimoghaddam K; Ghavamzadeh A; Ghaffari SH
Eur J Pharmacol; 2018 Feb; 820():274-285. PubMed ID: 29274334
[TBL] [Abstract][Full Text] [Related]
9. Complex I inhibition augments dichloroacetate cytotoxicity through enhancing oxidative stress in VM-M3 glioblastoma cells.
Ward NP; Poff AM; Koutnik AP; D'Agostino DP
PLoS One; 2017; 12(6):e0180061. PubMed ID: 28644886
[TBL] [Abstract][Full Text] [Related]
10. Synergistic anticancer potential of dichloroacetate and estradiol analogue exerting their effect via ROS-JNK-Bcl-2-mediated signalling pathways.
Stander XX; Stander BA; Joubert AM
Cell Physiol Biochem; 2015; 35(4):1499-526. PubMed ID: 25791820
[TBL] [Abstract][Full Text] [Related]
11. Sodium dichloroacetate selectively targets cells with defects in the mitochondrial ETC.
Stockwin LH; Yu SX; Borgel S; Hancock C; Wolfe TL; Phillips LR; Hollingshead MG; Newton DL
Int J Cancer; 2010 Dec; 127(11):2510-9. PubMed ID: 20533281
[TBL] [Abstract][Full Text] [Related]
12. Dichloroacetate Affects Mitochondrial Function and Stemness-Associated Properties in Pancreatic Cancer Cell Lines.
Tataranni T; Agriesti F; Pacelli C; Ruggieri V; Laurenzana I; Mazzoccoli C; Sala GD; Panebianco C; Pazienza V; Capitanio N; Piccoli C
Cells; 2019 May; 8(5):. PubMed ID: 31109089
[TBL] [Abstract][Full Text] [Related]
13. Dichloroacetate induces cell cycle arrest in human glioblastoma cells persistently infected with measles virus: a way for controlling viral persistent infection.
Takahashi M; Watari E; Takahashi H
Antiviral Res; 2015 Jan; 113():107-10. PubMed ID: 25433309
[TBL] [Abstract][Full Text] [Related]
14. Dichloroacetate, a selective mitochondria-targeting drug for oral squamous cell carcinoma: a metabolic perspective of treatment.
Ruggieri V; Agriesti F; Scrima R; Laurenzana I; Perrone D; Tataranni T; Mazzoccoli C; Lo Muzio L; Capitanio N; Piccoli C
Oncotarget; 2015 Jan; 6(2):1217-30. PubMed ID: 25544754
[TBL] [Abstract][Full Text] [Related]
15. The combined effect of dichloroacetate and 3-bromopyruvate on glucose metabolism in colorectal cancer cell line, HT-29; the mitochondrial pathway apoptosis.
Nikravesh H; Khodayar MJ; Behmanesh B; Mahdavinia M; Teimoori A; Alboghobeish S; Zeidooni L
BMC Cancer; 2021 Aug; 21(1):903. PubMed ID: 34364387
[TBL] [Abstract][Full Text] [Related]
16. Dichloroacetate induces apoptosis in endometrial cancer cells.
Wong JY; Huggins GS; Debidda M; Munshi NC; De Vivo I
Gynecol Oncol; 2008 Jun; 109(3):394-402. PubMed ID: 18423823
[TBL] [Abstract][Full Text] [Related]
17. [Possible mechanism of the selective action of the inhibitors of glycolysis in the endothelial cells and the human carcinoma cells in the culture].
Giliano NY; Bondarev GN; Konevega LV; Noskin LA; Zhurishkina EV; Alchinova IB
Patol Fiziol Eksp Ter; 2014; (4):78-85. PubMed ID: 25980231
[TBL] [Abstract][Full Text] [Related]
18. Multi-modality imaging to assess metabolic response to dichloroacetate treatment in tumor models.
Neveu MA; De Preter G; Joudiou N; Bol A; Brender JR; Saito K; Kishimoto S; Grégoire V; Jordan BF; Krishna MC; Feron O; Gallez B
Oncotarget; 2016 Dec; 7(49):81741-81749. PubMed ID: 28082726
[TBL] [Abstract][Full Text] [Related]
19. Metabolic targeting of EGFRvIII/PDK1 axis in temozolomide resistant glioblastoma.
Velpula KK; Guda MR; Sahu K; Tuszynski J; Asuthkar S; Bach SE; Lathia JD; Tsung AJ
Oncotarget; 2017 May; 8(22):35639-35655. PubMed ID: 28410193
[TBL] [Abstract][Full Text] [Related]
20. Targeting metabolism with arsenic trioxide and dichloroacetate in breast cancer cells.
Sun RC; Board PG; Blackburn AC
Mol Cancer; 2011 Nov; 10():142. PubMed ID: 22093145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
